NZ506417A
(en)
*
|
1998-02-17 |
2003-05-30 |
Tularik Inc |
Anti-viral pyrimidine derivatives
|
WO2000027828A2
(en)
*
|
1998-11-10 |
2000-05-18 |
Janssen Pharmaceutica N.V. |
2,4-disubstituted triazine derivatives with anti hiv activity
|
HU230394B1
(hu)
*
|
1998-11-10 |
2016-04-28 |
Janssen Pharmaceutica N.V. |
HIV-vírus szaporodását gátló pirimidin-származékok
|
ATE253915T1
(de)
|
1999-06-30 |
2003-11-15 |
Merck & Co Inc |
Src-kinase hemmende verbindungen
|
WO2001000214A1
(en)
*
|
1999-06-30 |
2001-01-04 |
Merck & Co., Inc. |
Src kinase inhibitor compounds
|
EP1206260A4
(en)
|
1999-06-30 |
2002-10-30 |
Merck & Co Inc |
SRC-KINASE INHIBITING COMPOUNDS
|
GB9919778D0
(en)
|
1999-08-21 |
1999-10-27 |
Zeneca Ltd |
Chemical compounds
|
BRPI0014271B1
(pt)
|
1999-09-24 |
2021-06-22 |
Janssen Pharmaceutica N.V. |
Partícula consistindo em uma dispersão de sólidos, uso da dita partícula, dispersão de sólidos, forma de dosagem farmacêutica, bem como processos de preparação de dita partícula, dispersão e forma de dosagem
|
WO2001025220A1
(en)
|
1999-10-07 |
2001-04-12 |
Amgen Inc. |
Triazine kinase inhibitors
|
US6410726B1
(en)
|
2000-01-12 |
2002-06-25 |
Tularik Inc. |
Arylsulfonic acid salts of pyrimidine-based antiviral
|
WO2001060816A1
(en)
*
|
2000-02-17 |
2001-08-23 |
Amgen Inc. |
Kinase inhibitors
|
ES2240449T3
(es)
*
|
2000-02-25 |
2005-10-16 |
F. Hoffmann-La Roche Ag |
Moduladores receptores de adenosina.
|
GB0004887D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
GB0004886D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
GB0004888D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
GB0004890D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
US7235551B2
(en)
*
|
2000-03-02 |
2007-06-26 |
Smithkline Beecham Corporation |
1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
|
GB0007371D0
(en)
|
2000-03-28 |
2000-05-17 |
Astrazeneca Uk Ltd |
Chemical compounds
|
ES2559273T3
(es)
*
|
2000-05-08 |
2016-02-11 |
Janssen Pharmaceutica Nv |
Profármacos de pirimidinas que inhiben la replicación del VIH
|
CA2406562C
(en)
*
|
2000-05-08 |
2009-09-15 |
Janssen Pharmaceutica N.V. |
Hiv replication inhibiting pyrimidines and triazines
|
GB0016877D0
(en)
|
2000-07-11 |
2000-08-30 |
Astrazeneca Ab |
Chemical compounds
|
GB0017676D0
(en)
*
|
2000-07-19 |
2000-09-06 |
Angeletti P Ist Richerche Bio |
Inhibitors of viral polymerase
|
GB0021726D0
(en)
|
2000-09-05 |
2000-10-18 |
Astrazeneca Ab |
Chemical compounds
|
US6660731B2
(en)
|
2000-09-15 |
2003-12-09 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
US7473691B2
(en)
*
|
2000-09-15 |
2009-01-06 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
WO2002022605A1
(en)
|
2000-09-15 |
2002-03-21 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
JP4524072B2
(ja)
|
2000-10-23 |
2010-08-11 |
グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー |
新規化合物
|
WO2002039958A2
(en)
*
|
2000-11-03 |
2002-05-23 |
Tularik Inc. |
Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
|
US20050250854A1
(en)
*
|
2000-11-03 |
2005-11-10 |
Amgen Inc. |
Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
|
US6989385B2
(en)
*
|
2000-12-21 |
2006-01-24 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
US20040127502A1
(en)
|
2001-01-31 |
2004-07-01 |
Synaptic Pharmaceutical Corporation |
Use of GAL3 antagonist for treatment of depression
|
US7081470B2
(en)
|
2001-01-31 |
2006-07-25 |
H. Lundbeck A/S |
Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
|
US20030130264A1
(en)
*
|
2001-02-16 |
2003-07-10 |
Tularik Inc. |
Methods of using pyrimidine-based antiviral agents
|
GB0103926D0
(en)
|
2001-02-17 |
2001-04-04 |
Astrazeneca Ab |
Chemical compounds
|
GB0113041D0
(en)
|
2001-05-30 |
2001-07-18 |
Astrazeneca Ab |
Chemical compounds
|
US6958340B2
(en)
*
|
2001-08-01 |
2005-10-25 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
US6939874B2
(en)
|
2001-08-22 |
2005-09-06 |
Amgen Inc. |
Substituted pyrimidinyl derivatives and methods of use
|
US7115617B2
(en)
|
2001-08-22 |
2006-10-03 |
Amgen Inc. |
Amino-substituted pyrimidinyl derivatives and methods of use
|
BR0212904A
(pt)
*
|
2001-09-21 |
2004-10-13 |
Sanofi Synthelabo |
Derivados substituìdos de 2-pirimidinil-6,7,8,9-tetraidropirimido-{1,2-a}pirimidin- 4-ona e 7-pirimidinil-2,3-diidroimidazo-{1,2-a}pirimi-din-5(1h)-on a para distúrbios neurodegenerativos
|
WO2003032994A2
(de)
|
2001-10-17 |
2003-04-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
5-substituierte 4-amino-2-phenylamino-pyrimidinderivate und ihre verwendung als beta-amyloid modulatoren
|
CA2463989C
(en)
|
2001-10-17 |
2012-01-31 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pyrimidine derivatives, pharmaceutical compositions containing these compounds, the use thereof and process for the preparation thereof
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
RU2004126671A
(ru)
*
|
2002-02-06 |
2005-04-10 |
Вертекс Фармасьютикалз Инкорпорейтед (Us) |
Гетероарилсоединения, полезные в качестве ингибиторов gsk-3
|
WO2003076434A1
(en)
|
2002-03-09 |
2003-09-18 |
Astrazeneca Ab |
4- imidazolyl substuited pyrimidine derivatives with cdk inhibitiory activity
|
GB0205690D0
(en)
|
2002-03-09 |
2002-04-24 |
Astrazeneca Ab |
Chemical compounds
|
GB0205693D0
(en)
|
2002-03-09 |
2002-04-24 |
Astrazeneca Ab |
Chemical compounds
|
GB0205688D0
(en)
|
2002-03-09 |
2002-04-24 |
Astrazeneca Ab |
Chemical compounds
|
US20040009981A1
(en)
*
|
2002-03-15 |
2004-01-15 |
David Bebbington |
Compositions useful as inhibitors of protein kinases
|
KR100516434B1
(ko)
*
|
2002-04-04 |
2005-09-22 |
(주) 비엔씨바이오팜 |
6-(4-치환된-아닐리노)피리미딘 유도체, 그 제조방법 및 이를 포함하는 항바이러스용 약학적 조성물
|
AU2003225072A1
(en)
|
2002-04-19 |
2003-11-03 |
Smithkline Beecham Corporation |
Novel compounds
|
MY141867A
(en)
*
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
CN1665789A
(zh)
*
|
2002-06-28 |
2005-09-07 |
山之内制药株式会社 |
二氨基嘧啶酰胺衍生物
|
GB0217431D0
(en)
|
2002-07-27 |
2002-09-04 |
Astrazeneca Ab |
Novel compounds
|
EP1534286B1
(en)
|
2002-07-29 |
2009-12-09 |
Rigel Pharmaceuticals, Inc. |
Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
|
EA200500299A1
(ru)
|
2002-08-02 |
2005-08-25 |
Вертекс Фармасьютикалз Инкорпорейтед |
Пиразольные композиции, используемые в качестве ингибиторов gsk-3
|
EP1389461A1
(en)
*
|
2002-08-14 |
2004-02-18 |
Axxima Pharmaceuticals Aktiengesellschaft |
Pyrimidones with antiviral properties
|
WO2004016271A1
(en)
*
|
2002-08-14 |
2004-02-26 |
Axxima Pharmaceuticals Ag |
Pyrimidones as antiviral agents
|
DE10238722A1
(de)
|
2002-08-23 |
2004-03-11 |
Bayer Ag |
Selektive Phosphodiesterase 9A-Inhibitoren als Arzneimittel zur Verbesserung kognitiver Prozesse
|
AU2003255819A1
(en)
|
2002-08-24 |
2004-03-11 |
Astrazeneca Ab |
Pyrimidine derivatives as modulators of chemokine receptor activity
|
DE10251914A1
(de)
|
2002-11-08 |
2004-05-19 |
Bayer Ag |
Substituierte Chinazoline
|
US7109337B2
(en)
|
2002-12-20 |
2006-09-19 |
Pfizer Inc |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
ATE458731T1
(de)
|
2002-12-20 |
2010-03-15 |
Pfizer Prod Inc |
Pyrimidin-derivate zur behandlung von anormalem zellwachstum
|
DE10319612A1
(de)
|
2003-05-02 |
2004-11-18 |
Bayer Healthcare Ag |
Substituierte Dihydrochinazoline
|
WO2004072029A2
(en)
*
|
2003-02-06 |
2004-08-26 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyridazines useful as inhibitors of protein kinases
|
US7157455B2
(en)
|
2003-02-10 |
2007-01-02 |
Hoffmann-La Roche Inc. |
4-Aminopyrimidine-5-one derivatives
|
DE10305785A1
(de)
*
|
2003-02-12 |
2004-08-26 |
Bayer Healthcare Ag |
Dihydrochinazoline
|
AU2004212957A1
(en)
*
|
2003-02-14 |
2004-09-02 |
Smithkline Beecham Corporation |
Novel compounds
|
DE10320780A1
(de)
|
2003-05-09 |
2005-01-20 |
Bayer Healthcare Ag |
Heterocyclyl-substituierte Dihydrochinazoline
|
DE10320785A1
(de)
|
2003-05-09 |
2004-11-25 |
Bayer Healthcare Ag |
6-Arylmethyl-substituierte Pyrazolopyrimidine
|
GB0311276D0
(en)
|
2003-05-16 |
2003-06-18 |
Astrazeneca Ab |
Chemical compounds
|
GB0311274D0
(en)
|
2003-05-16 |
2003-06-18 |
Astrazeneca Ab |
Chemical compounds
|
KR100502395B1
(ko)
*
|
2003-06-04 |
2005-07-19 |
(주) 비엔씨바이오팜 |
4-[4-(4-모르포리노)아닐리노]피리미딘 유도체, 그제조방법 및 이를 포함하는 항바이러스용 약학적 조성물.
|
KR100502394B1
(ko)
*
|
2003-06-04 |
2005-07-19 |
(주) 비엔씨바이오팜 |
2-[2-(4-모르포리노)에틸아미노]피리딘 유도체, 그제조방법 및 이를 포함하는 항바이러스용 약학적 조성물
|
DE10328479A1
(de)
|
2003-06-25 |
2005-01-13 |
Bayer Ag |
6-Arylamino-5-cyano-4-pyrimidinone
|
DK1656372T3
(da)
*
|
2003-07-30 |
2013-07-01 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidindiaminforbindelser til anvendelse til behandling eller forebyggelse af autoimmunsygdomme
|
DE10352499A1
(de)
*
|
2003-11-11 |
2005-06-09 |
Bayer Healthcare Ag |
Substituierte Dihydrochinazoline II
|
CN100554264C
(zh)
|
2003-11-24 |
2009-10-28 |
弗·哈夫曼-拉罗切有限公司 |
吡唑基与咪唑基嘧啶
|
CN1902193B
(zh)
*
|
2003-12-04 |
2011-07-13 |
沃泰克斯药物股份有限公司 |
可用作蛋白激酶抑制剂的喹喔啉
|
TWI355894B
(en)
|
2003-12-19 |
2012-01-11 |
Du Pont |
Herbicidal pyrimidines
|
TW200533357A
(en)
*
|
2004-01-08 |
2005-10-16 |
Millennium Pharm Inc |
2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases
|
TW200528101A
(en)
|
2004-02-03 |
2005-09-01 |
Astrazeneca Ab |
Chemical compounds
|
DE102004022672A1
(de)
|
2004-05-07 |
2005-11-24 |
Bayer Healthcare Ag |
Substituierte Azachinazoline
|
MXPA06011658A
(es)
|
2004-05-14 |
2006-12-14 |
Pfizer Prod Inc |
Derivados de pirimidina para el tratamiento del crecimiento celular anormal.
|
BRPI0510980A
(pt)
|
2004-05-14 |
2007-11-27 |
Pfizer Prod Inc |
derivados de pirimidina para o tratamento do crescimento anormal de células
|
BRPI0510963A
(pt)
|
2004-05-14 |
2007-11-20 |
Pfizer Prod Inc |
derivados pirimidina para o tratamento do crescimento anormal de células
|
EP1598343A1
(de)
*
|
2004-05-19 |
2005-11-23 |
Boehringer Ingelheim International GmbH |
2-Arylaminopyrimidine als PLK Inhibitoren
|
AU2005279045B2
(en)
|
2004-08-28 |
2009-11-26 |
Astrazeneca Ab |
Pyrimidine sulphonamide derivatives as chemokine receptor modulators
|
US7491720B2
(en)
|
2004-10-29 |
2009-02-17 |
Banyu Pharmaceutical Co., Ltd. |
Aminopyridine derivatives having Aurora A selective inhibitory action
|
WO2006055831A2
(en)
*
|
2004-11-17 |
2006-05-26 |
Miikana Therapeutics, Inc. |
Kinase inhibitors
|
WO2006068770A1
(en)
|
2004-11-24 |
2006-06-29 |
Rigel Pharmaceuticals, Inc. |
Spiro-2, 4-pyrimidinediamine compounds and their uses
|
NZ555474A
(en)
*
|
2004-12-17 |
2010-10-29 |
Astrazeneca Ab |
4-(4-(imidazol-4-yl) pyrimidin-2-ylamino) benzamides as CDK inhibitors
|
US7187123B2
(en)
*
|
2004-12-29 |
2007-03-06 |
Dupont Displays, Inc. |
Display device
|
ATE519759T1
(de)
|
2004-12-30 |
2011-08-15 |
Exelixis Inc |
Pyrimidinderivate als kinasemodulatoren und anwendungsverfahren
|
CA2591948C
(en)
|
2005-01-19 |
2013-11-12 |
Rigel Pharmaceuticals, Inc. |
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
|
CN101155800B
(zh)
|
2005-02-04 |
2012-05-23 |
阿斯利康(瑞典)有限公司 |
可用作激酶抑制剂的吡唑基氨基吡啶衍生物
|
PL1853588T3
(pl)
|
2005-02-16 |
2008-11-28 |
Astrazeneca Ab |
Związki chemiczne
|
SG160438A1
(en)
*
|
2005-03-25 |
2010-04-29 |
Glaxo Group Ltd |
Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5- d]pyrimidin-2(1h)-one derivatives
|
AR053346A1
(es)
|
2005-03-25 |
2007-05-02 |
Glaxo Group Ltd |
Compuesto derivado de 8h -pirido (2,3-d) pirimidin -7 ona 2,4,8- trisustituida composicion farmaceutica y uso para preparar una composicion para tratamiento y profilxis de una enfermedad mediada por la quinasa csbp/ rk/p38
|
US7423042B2
(en)
*
|
2005-03-25 |
2008-09-09 |
Glaxo Group Limited |
Compounds
|
TW200724142A
(en)
|
2005-03-25 |
2007-07-01 |
Glaxo Group Ltd |
Novel compounds
|
EP1883302A4
(en)
*
|
2005-05-03 |
2009-05-20 |
Rigel Pharmaceuticals Inc |
JAK KINASE HEMMER AND ITS USE
|
PL1877384T3
(pl)
|
2005-05-06 |
2011-09-30 |
Du Pont |
Sposób wytwarzania opcjonalnie 2-podstawionych kwasów 1,6-dihydro-6-okso-4-pirymidynokarboksylowych
|
MX2007014328A
(es)
|
2005-05-16 |
2008-02-12 |
Astrazeneca Ab |
Compuestos quimicos.
|
EP1888536B1
(en)
*
|
2005-05-16 |
2010-04-28 |
E.I. Du Pont De Nemours And Company |
Process for preparing substituted pyrimidines
|
JP5225079B2
(ja)
|
2005-06-08 |
2013-07-03 |
ライジェル ファーマシューティカルズ, インコーポレイテッド |
Jak経路の阻害のための組成物および方法
|
US20070203161A1
(en)
|
2006-02-24 |
2007-08-30 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
DE102005027517A1
(de)
|
2005-06-15 |
2006-12-21 |
Bayer Healthcare Ag |
Verfahren zur Herstellung von Dihydrochinazolinen
|
JP4278172B2
(ja)
*
|
2005-07-30 |
2009-06-10 |
アストラゼネカ アクチボラグ |
増殖性疾患の治療において使用するためのイミダゾリル−ピリミジン化合物
|
WO2007022384A2
(en)
*
|
2005-08-18 |
2007-02-22 |
Vertex Pharmaceuticals Incorporated |
Pyrazine kinase inhibitors
|
US7563787B2
(en)
*
|
2005-09-30 |
2009-07-21 |
Miikana Therapeutics, Inc. |
Substituted pyrazole compounds
|
EP1934213A1
(en)
|
2005-09-30 |
2008-06-25 |
Astra Zeneca AB |
Imidazo [1,2-a] pyridine having anti-cell-proliferation activity
|
AU2006307657B2
(en)
|
2005-10-28 |
2010-10-28 |
Astrazeneca Ab |
4- (3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer
|
NZ594383A
(en)
*
|
2005-11-03 |
2013-05-31 |
Vertex Pharma |
Aminopyrimidines useful as kinase inhibitors
|
TWI417095B
(zh)
|
2006-03-15 |
2013-12-01 |
Janssen Pharmaceuticals Inc |
1,4-二取代之3-氰基-吡啶酮衍生物及其作為mGluR2-受體之正向異位性調節劑之用途
|
DE602007008545D1
(de)
|
2006-03-31 |
2010-09-30 |
Janssen Pharmaceutica Nv |
Benzoimidazol-2-yl pyridine und pyrazine als modulatoren des histamin-h4-rezeptors
|
TW200811169A
(en)
*
|
2006-05-26 |
2008-03-01 |
Astrazeneca Ab |
Chemical compounds
|
CA2656290A1
(en)
*
|
2006-07-05 |
2008-01-10 |
Exelixis, Inc. |
Methods of using igf1r and abl kinase modulators
|
NZ576750A
(en)
*
|
2006-11-02 |
2012-01-12 |
Vertex Pharma |
Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases
|
EP2099787B1
(en)
*
|
2006-12-19 |
2010-07-21 |
Vertex Pharmaceuticals, Inc. |
Aminopyrimidines useful as inhibitors of protein kinases
|
US20100104567A1
(en)
|
2007-03-05 |
2010-04-29 |
Kyowa Hakko Kirin Co., Ltd. |
Pharmaceutical composition
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
NZ579483A
(en)
|
2007-03-09 |
2012-07-27 |
Vertex Pharma |
Aminopyridines useful as inhibitors of protein kinases
|
RU2009137390A
(ru)
*
|
2007-03-09 |
2011-04-20 |
Вертекс Фармасьютикалз Инкорпорейтед (Us) |
Аминопиримидины, пригодные в качестве ингибиторов протеинкиназ
|
CN101663295B
(zh)
*
|
2007-03-09 |
2014-11-05 |
沃泰克斯药物股份有限公司 |
可用作蛋白激酶抑制剂的氨基嘧啶类化合物
|
MX2009011059A
(es)
|
2007-04-13 |
2009-11-26 |
Vertex Pharma |
Aminopirimidinas utiles como inhibidores de cinasas.
|
CA2684447C
(en)
|
2007-04-18 |
2012-01-24 |
Pfizer Products Inc. |
Sulfonyl amide derivatives for the treatment of abnormal cell growth
|
MX2009011811A
(es)
*
|
2007-05-02 |
2010-01-14 |
Vertex Pharma |
Aminopirimidinas utiles como inhibidores de cinasa.
|
AU2008247594A1
(en)
*
|
2007-05-02 |
2008-11-13 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as kinase inhibitors
|
JP5389785B2
(ja)
|
2007-05-02 |
2014-01-15 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
キナーゼ阻害剤として有用なチアゾールおよびピラゾール
|
UA99459C2
(xx)
|
2007-05-04 |
2012-08-27 |
Астразенека Аб |
ПОХІДНІ 9-(ПІРАЗОЛ-3-ІЛ)-9H-ПУРИН-2-АМІНУ І 3-(ПІРАЗОЛ-3-ІЛ)-3H-ІМІДАЗО$4,5-b]ПІРИДИН-5-АМІНУ ТА ЇХ ЗАСТОСУВАННЯ ДЛЯ ЛІКУВАННЯ РАКУ$ПРОИЗВОДНЫЕ 9-(ПИРАЗОЛ-3-ИЛ)-9H-ПУРИН-2-АМИНА И 3-(ПИРАЗОЛ-3-ИЛ)-3H-ИМИДАЗО$4,5-b]ПИРИДИН-5-АМИНА И ИХ ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАКА
|
JP2010528021A
(ja)
*
|
2007-05-24 |
2010-08-19 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
キナーゼのインヒビターとして有用なチアゾールおよびピラゾール
|
US20090029992A1
(en)
*
|
2007-06-11 |
2009-01-29 |
Agoston Gregory E |
Substituted pyrazole compounds
|
NZ582879A
(en)
*
|
2007-07-31 |
2012-03-30 |
Vertex Pharma |
Process for preparing 5-fluoro-1h-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof
|
PT2200985E
(pt)
|
2007-09-14 |
2011-07-21 |
Ortho Mcneil Janssen Pharm |
4-(aril-x-fenil)-1h-piridin-2-onas 1,3-dissubstituídas
|
JP5433579B2
(ja)
|
2007-09-14 |
2014-03-05 |
ジャンセン ファーマシューティカルズ, インコーポレイテッド. |
1,3−二置換−4−フェニル−1h−ピリジン−2−オン
|
UA100126C2
(xx)
|
2007-09-14 |
2012-11-26 |
Аддекс Фарма С.А. |
1',3'-дизаміщені 4-феніл-3,4,5,6-тетрагідро-2h,1'h-$1,4']біпіридиніл-2'-они$1',3'-дизамещенные 4-фенил-3,4,5,6-тетрагидро-2h,1'h-$1,4']бипиридинил-2'-оны
|
CN101861316B
(zh)
|
2007-11-14 |
2013-08-21 |
奥梅-杨森制药有限公司 |
咪唑并[1,2-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
|
PE20091211A1
(es)
|
2007-11-30 |
2009-09-14 |
Boehringer Ingelheim Int |
Derivados de pirazolopirimidina como moduladores de pde9a
|
DE102007061757A1
(de)
|
2007-12-20 |
2009-06-25 |
Bayer Healthcare Ag |
Substituierte 2-Phenylpyrimidin-5-carbonsäuren und ihre Verwendung
|
DE102007061756A1
(de)
|
2007-12-20 |
2009-06-25 |
Bayer Healthcare Ag |
Substituierte 4-Aminopyrimidin-5-carbonsäuren und ihre Verwendung
|
UA105362C2
(xx)
|
2008-04-02 |
2014-05-12 |
Бьорингер Ингельхайм Интернациональ Гмбх |
Похідні 1-гетероцикліл-1,5-дигідропіразоло$3,4-d]піримідин-4-ону та їх застосування як модулятори pde9a$производные 1-гетероциклил-1,5-дигидропиразоло$3,4-d] пиримидин-4-она и их применение в качестве модуляторов pde9a
|
US9371311B2
(en)
|
2008-06-30 |
2016-06-21 |
Janssen Pharmaceutica Nv |
Benzoimidazol-2-yl pyrimidine derivatives
|
AU2009267159B2
(en)
*
|
2008-06-30 |
2014-05-15 |
Janssen Pharmaceutica Nv |
Process for the preparation of benzoimidazol-2-yl pyrimidine derivatives
|
ME02154B
(me)
|
2008-06-30 |
2015-10-20 |
Janssen Pharmaceutica Nv |
Proces za pripremu supstituisanih derivata pirimidina
|
AU2009289784B2
(en)
|
2008-09-02 |
2012-03-22 |
Addex Pharma S.A. |
3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
|
KR20110050549A
(ko)
*
|
2008-09-03 |
2011-05-13 |
버텍스 파마슈티칼스 인코포레이티드 |
공-결정 및 이를 포함하는 제약 제제
|
MX2011002340A
(es)
|
2008-09-08 |
2011-04-04 |
Boehringer Ingelheim Int |
Pirazolopirimidinas y su uso para el tratamiento de trastornos del snc.
|
RU2517181C2
(ru)
|
2008-10-16 |
2014-05-27 |
Орто-Макнейл-Янссен Фармасьютикалз, Инк. |
Производные индола и бензоморфолина в качестве модулятора метаботропных глутаматных рецепторов
|
BRPI0921333A2
(pt)
|
2008-11-28 |
2015-12-29 |
Addex Pharmaceuticals Sa |
derivados de indol e benzoxazina como moduladores de receptores de glutamato metabotrópicos
|
UY32306A
(es)
*
|
2008-12-09 |
2010-07-30 |
Gilead Sciences Inc |
Derivados de pteridinona y pirimidinodiazepinona y composiciones farmacéuticas que modulan en forma selectiva los receptores tipo toll, métodos y usos
|
AP2011005819A0
(en)
|
2009-03-31 |
2011-08-31 |
Boehringer Ingelheim Int |
1-heterocyclyl-1, 5-dihydropyrazolo[3,4-D] pyrimidin -4-one derivatives and their use as PDE9A modulators.
|
JP2012524063A
(ja)
*
|
2009-04-15 |
2012-10-11 |
アストラゼネカ・アクチエボラーグ |
アルツハイマー病などのグリコーゲンシンターゼキナーゼ3関連障害の治療に有用なイミダゾール置換ピリミジン
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
KR101753826B1
(ko)
|
2009-05-12 |
2017-07-04 |
얀센 파마슈티칼즈, 인코포레이티드 |
1,2,4―트리아졸로[4,3―a]피리딘 유도체 및 신경정신 질환의 치료 또는 예방을 위한 이들의 용도
|
BRPI1010831A2
(pt)
|
2009-05-12 |
2016-04-05 |
Addex Pharmaceuticals Sa |
derivados de 1,2,4-triazolo[4,3-a]piridina e seu como moduladores alostéricos positivos de receptores de mglur2
|
PL2585467T3
(pl)
*
|
2010-06-24 |
2016-09-30 |
|
PIRAZOLO[1,5-A]PIRYMIDYNY i –TRIAZYNY JAKO ŚRODKI ANTYWIRUSOWE
|
JP5756176B2
(ja)
|
2010-08-12 |
2015-07-29 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
6−シクロアルキル−1,5−ジヒドロ−ピラゾロ(3,4−d)ピリミジ−4−オン誘導体及びpde9a阻害剤としてのその使用
|
CA2816957A1
(en)
|
2010-11-07 |
2012-05-10 |
Targegen, Inc. |
Compositions and methods for treating myelofibrosis
|
EP2649069B1
(en)
|
2010-11-08 |
2015-08-26 |
Janssen Pharmaceuticals, Inc. |
1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
ES2536433T3
(es)
|
2010-11-08 |
2015-05-25 |
Janssen Pharmaceuticals, Inc. |
Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
|
AU2011328203B2
(en)
|
2010-11-08 |
2015-03-19 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
|
US8809345B2
(en)
|
2011-02-15 |
2014-08-19 |
Boehringer Ingelheim International Gmbh |
6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders
|
ES2887303T3
(es)
|
2011-04-08 |
2021-12-22 |
Janssen Sciences Ireland Unlimited Co |
Derivados de pirimidina para el tratamiento de infecciones víricas
|
MX347596B
(es)
|
2011-11-09 |
2017-05-03 |
Janssen Sciences Ireland Uc |
Derivados de purina para el tratamiento de infecciones viricas.
|
JP6122868B2
(ja)
|
2011-12-22 |
2017-04-26 |
ギリアード サイエンシーズ, インコーポレイテッド |
抗ウイルス剤としてのピラゾロ[1,5−a]ピリミジン
|
AU2013221286B2
(en)
*
|
2012-02-17 |
2017-06-15 |
Abbvie Inc. |
Diaminopyrimidines useful as inhibitors of the human respiratory syncytial virus (RSV)
|
US9187453B2
(en)
|
2012-03-28 |
2015-11-17 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
SG10201610166VA
(en)
|
2012-04-17 |
2017-01-27 |
Gilead Sciences Inc |
Compounds and methods for antiviral treatment
|
JP6250046B2
(ja)
|
2012-07-13 |
2017-12-20 |
ヤンセン・サイエンシズ・アイルランド・ユーシー |
ウイルス感染症の処置のための大環状プリン
|
BR112015007586B1
(pt)
|
2012-10-10 |
2021-02-09 |
Janssen Sciences Ireland Uc |
derivados de pirrolo[3,2-d]pirimidina, seu uso e composição farmacêutica que os compreende
|
DK2925729T3
(en)
|
2012-11-16 |
2018-01-22 |
Janssen Sciences Ireland Uc |
HETEROCYCLIC SUBSTITUTED 2-AMINOQUINAZOLINE DERIVATIVES FOR TREATING VIRUS INFECTIONS
|
AU2014220717B2
(en)
|
2013-02-21 |
2018-03-29 |
Janssen Sciences Ireland Uc |
2-aminopyrimidine derivatives for the treatment of viral infections
|
EP3660011A1
(en)
|
2013-03-06 |
2020-06-03 |
Janssen Pharmaceutica NV |
Benzoimidazol-2-yl pyrimidine modulators of the histamine h4 receptor
|
MX366481B
(es)
|
2013-03-29 |
2019-07-09 |
Janssen Sciences Ireland Uc |
Deaza-purinonas macrociclicas para el tratamiento de infecciones virales.
|
EA034674B1
(ru)
|
2013-05-24 |
2020-03-05 |
Янссен Сайенсиз Айрлэнд Юси |
Производные пиридона для лечения нарушений, в которое вовлечены модуляции tlr7 и/или tlr8
|
JO3368B1
(ar)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
|
UA117590C2
(uk)
|
2013-06-27 |
2018-08-27 |
ЯНССЕН САЙЄНСЕЗ АЙРЛЕНД ЮСі |
ПОХІДНІ ПІРОЛО[3,2-d]ПІРИМІДИНУ ДЛЯ ЛІКУВАННЯ ВІРУСНИХ ІНФЕКЦІЙ ТА ІНШИХ ЗАХВОРЮВАНЬ
|
EA036162B1
(ru)
|
2013-07-30 |
2020-10-08 |
Янссен Сайенсиз Айрлэнд Юси |
Производные тиено[3,2-d]пиримидинов для лечения вирусных инфекций
|
JO3367B1
(ar)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
|
MX2016009471A
(es)
|
2014-01-21 |
2016-10-13 |
Janssen Pharmaceutica Nv |
Combinaciones que comprenden agonistas ortostericos o moduladores alostericos positivos del receptor glutamatergico metabotropico de subtipo 2 y su uso.
|
HUE045610T2
(hu)
|
2014-01-21 |
2020-01-28 |
Janssen Pharmaceutica Nv |
2-es altípusú metabotróp glutamáterg receptor pozitív allosztérikus modulátorait vagy ortosztérikus agonistáit tartalmazó kombinációk és alkalmazásuk
|
ES2830743T3
(es)
|
2016-01-29 |
2021-06-04 |
Samjin Pharm Co Ltd |
Nuevo derivado de imidazol que tiene actividad inhibidora de JNK y uso del mismo
|
WO2018002319A1
(en)
|
2016-07-01 |
2018-01-04 |
Janssen Sciences Ireland Uc |
Dihydropyranopyrimidines for the treatment of viral infections
|
SG10202010317VA
(en)
|
2016-09-29 |
2020-11-27 |
Janssen Sciences Ireland Unlimited Co |
Pyrimidine prodrugs for the treatment of viral infections and further diseases
|
TW201945003A
(zh)
|
2018-03-01 |
2019-12-01 |
愛爾蘭商健生科學愛爾蘭無限公司 |
2,4-二胺基喹唑啉衍生物及其醫學用途
|